Monilola Olayioye

20PUBLICATIONS
62CO-AUTHORS
BiomaterialsTissue engineeringMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|Aug 11, 2026
Sequential stenciling to reconstitute 2D microtissues for multicellular and synthetic signaling architectures.

|May 19, 2026
Novel bispecific T-cell engagers overcoming acquired EGFR resistance.

|Jan 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

Stella Asmanidou, Julia Thiel, Thomas L Ekstrom

|May 12, 2025
Integrated mathematical and experimental modeling uncovers enhanced EMT plasticity upon loss of the DLC1 tumor suppressor.

Sebastian Höpfl, Merih Özverin, Helena Nowack

|Mar 07, 2024
Repeat DNA methylation is modulated by adherens junction signaling.

Lisa-Marie Brenner, Florian Meyer, Haiqian Yang

Pageof 4

Frequent Collaborators

5 joint publications

Oliver Seifert

4 joint publications

Lennart Kühl

4 joint publications

Roland E Kontermann

3 joint publications

Alexander Rau